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ABSTRACT  
 
Background 
Most risk models for cancer are either specific to individual cancers or include complex or 
predominantly non-modifiable risk factors.  
Methods 
We developed lifestyle-based models for the five cancers for which the most cases are 
potentially preventable through lifestyle change in the UK (lung, colorectal, bladder, kidney 
and oesophageal for men and breast, lung, colorectal, endometrial and kidney for women). 
We selected lifestyle risk factors from the European Code against Cancer and obtained 
estimates of relative risks from meta-analyses of observational studies. We used mean values 
for risk factors from nationally representative samples and mean 10-year estimated absolute 
risks from routinely available sources. We then assessed the performance of the models in 
23,768 participants in the EPIC-Norfolk cohort who had no history of the five selected 
cancers at baseline.  
Results 
In men the combined risk model showed good discrimination (AUC: 0.71, 95% CI 0.69-0.73) 
and calibration. Discrimination was lower in women (AUC: 0.59 95% CI 0.57 – 0.61) but 
calibration was good. In both sexes the individual models for lung cancer had the highest 
AUCs (0.83, 95%CI 0.80-0.85 for men and 0.82, 95%CI 0.76-0.87 for women). The lowest 
AUCs were for breast cancer in women and kidney cancer in men.  
Conclusions 
The discrimination and calibration of the models are both reasonable, with the discrimination 
for individual cancers comparable or better than many other published risk models. 
Impact 
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These models could be used to demonstrate the potential impact of lifestyle change on risk of 
cancer to promote behaviour change. 
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INTRODUCTION 
Previous research has shown that providing cancer risk information to individuals can 
improve accuracy of risk perception(1–3), enhance response efficacy(4) and increase 
intention to have cancer screening(5,6). Additionally, in the only trial assessing the impact of 
cancer risk tools in primary care on lifestyle behaviours, participants in the intervention group 
were significantly more likely to report increased daily fruit and vegetable intake and 
physical activity after six months(7). 
 
Providing individualised estimates of risk of cancer in primary care settings, alongside 
demonstration of the impact of lifestyle change on that risk, may therefore help motivate 
change among individuals and complement wider collective approaches to shifting 
population distributions of behaviour and risk factors. Studies of healthcare professionals and 
members of the public in the UK have shown that both groups support provision of cancer 
risk information in primary care(8,9). However, in order to successfully incorporate such risk 
information into practice, there is a need for risk algorithms which include modifiable risk 
factors that are either routinely available in electronic medical records or can easily be 
obtained at new patient registration or within consultations. 
 
The incidence of individual cancers is also low compared to other conditions, such as 
cardiovascular disease. Consequently, in one study the first reaction of almost all participants 
to being presented with their 10-year absolute risk of an individual cancer was that it was low 
and not concerning(9). Providing context for the risk estimates through comparison to other 
people was also needed. There is, therefore, a need for models that can estimate an 
individual’s combined absolute risk of a number of cancers based on current values of 
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lifestyle risk factors, and which can be used to calculate relative risk comparing current 
values with either average or recommended values of the risk factors. 
 
A number of risk models for cancer already exist. However, most  are specific to individual 
cancers(10–13) and while two collections of models exist for multiple cancers, the 
QCancer10 models(14) and the Disease Risk Index(15), to our knowledge, no models that 
predict risk of multiple cancers together have been published. Additionally, the risk models 
for individual cancers often include multiple complex risk factors, such as breast density, 
exposure to asbestos or a past history of colorectal adenomas,  or include few modifiable risk 
factors. Of the 17 models for breast cancer identified in one systematic review(10) for 
example, less than half included BMI and only one physical activity.   
 
 
We therefore aimed to develop and validate a lifestyle-based prediction model for the five 
most common preventable cancers in men and women.  
 
MATERIALS AND METHODS 
We developed and validated a risk prediction model in accordance with the Transparent 
Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis 
(TRIPOD) guidelines(16) 
 
Cancer outcomes 
We included as outcomes the five cancers for which the most cases are potentially 
preventable through lifestyle change in the UK for men and women from Cancer Research 
UK data (http://www.cancerresearchuk.org/health-professional/cancer-
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statistics/risk/preventable-cancers). We excluded melanoma as the evidence to date suggests 
that risk is influenced by exposure to sun as a child rather than sun protection habits in 
adulthood (17). For men these are lung, colorectal, bladder, kidney and oesophageal cancer. 
Together they account for 38% of cancer cases amongst men in the UK and across the five 
cancers 45,000 cases are estimated to have been preventable in 2011, 25% of all cancer cases 
in men.  For women these are breast, lung, colorectal, endometrial and kidney cancer. 
Together they account for 61% of cancer cases amongst women in the UK and across the five 
cancers 48,000 cases are estimated to have been preventable in 2011, 28% of all cancer cases 
in women.  
 
Development of risk models 
Risk factors 
We selected lifestyle risk factors for each of these cancers based on the European Code 
against Cancer 4
th
 Edition(18–22).  For each cancer we included all risk factors considered 
convincing or probable by the panels of experts cited within the European Code against 
Cancer 4
th
 Edition, except for: dietary fibre for colorectal cancer in view of the difficulty 
obtaining reliable self-report measures for fibre intake using a single question; radon levels 
for lung cancer as this may not always be under the control of the individual; breastfeeding 
for breast cancer as in most cases this will not be modifiable for the target age range for these 
risk models (40-79 years); and hormone replacement therapy (HRT) for breast and 
endometrial cancer because the relationship between HRT use and cancer depends on 
multiple factors, including type of HRT, route of administration(23), and age at initiation, and 
the decision to take HRT is a complex decision requiring a balance of risks and benefits and 
one that should not be made on the basis of future cancer risk alone(24). . We then obtained 
estimates of the association of each lifestyle factor with each of the relevant cancers from 
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published meta-analyses of observational studies(25,26,35,36,27–34). For all associations 
except alcohol with colorectal cancer we assumed a log linear relationship between exposure 
and risk. To incorporate the increasing evidence that body mass index (BMI) is associated 
with increased risk of post-menopausal breast cancer but inversely associated with breast 
cancer before the menopause(30), we included different estimates of the association between 
BMI and breast cancer in those <50 years of age and those ≥ 50 years. No other significant 
interactions between the risk factors included for the chosen cancers have been reported(30).   
 
Estimates of average values of risk factors 
We estimated average population values of each risk factor in ten year age groups (40-49, 50-
59, 60-69 and 70-79 years) in men and women using nationally representative English 
population surveys. As the latent period between ‘exposure’ to the lifestyle factors and the 
subsequent increase in cancer risk is not known, we assumed this would be, on average, 10 
years as in previous publications(26,37–41). We, therefore, used the Health Survey for 
England (HSE) 2005 (available from: https://digital.nhs.uk/data-and-
information/publications/statistical/health-survey-for-england) to obtain population average 
values for BMI, smoking status, and fruit and vegetable consumption and data from the 
National Diet and Nutrition survey (NDNS) years 1-4 (2008/12) (available from: 
https://discover.ukdataservice.ac.uk/catalogue/?sn=6533), the closest years to 2005 that 
included adults up to age 79, for red and processed meat consumption, alcohol intake and 
physical activity.  
 
Details of the sampling design and methods of both datasets have been described in detail 
alongside the data (see https://discover.ukdataservice.ac.uk/catalogue/?sn=6533). In brief, the 
HSE is an annual survey designed to measure health and health-related behaviours in a 
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nationally representative sample of adults and children living in private households in 
England. In 2005 it also included an additional nationally representative general population 
sample of adults aged 65 years and over. For this analysis we used data on self-report 
smoking status, BMI, and portions of fruit and vegetable consumption per day. Each portion 
of fruit or vegetables was considered 80g based on the British Dietetic Association portion 
sizes food factsheet (available from: 
https://www.bda.uk.com/foodfacts/portionsizesfoodfactsheet.pdf) and all analyses were 
performed with weighting to adjust for non-contact and non-response at both household and 
individual level.  
 
The NDNS is an annual cross-sectional survey that began in 2008 and covers a representative 
sample of approximately 1000 people living in private households in the UK per year. For 
this analysis red meat, processed meat and alcohol consumption (g/day) were obtained from 
responses to a self-completed food diary. Eight grams of alcohol were estimated as one unit. 
Physical activity in METs was derived from time spent at moderate or vigorous physical 
activity, calculated from the Recent physical activity questionnaire (RPAQ)(42). 10 minutes 
of activity was considered 1 metabolic equivalent (MET)(43). As for the HSE, all analyses 
were performed with weighting to adjust for non-contact and non-response.  
 
Estimates of  relative risk comparing observed with average values of all the risk factors for 
separate cancers 
For each of the five cancers, we used the estimates of associations between each risk factor 
and each cancer to create a formula for the relative risk comparing observed with average 
values of all the risk factors. For continuous risk factors the relative risk was given by: 
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 Relative risk (χ) = (risk per unit)^(observed value – average value) 
 
For smoking, the other categorical risk factor, the relative risk was given by: 
 
 Relative risk (smoking) = (risk for current smokers x proportion of population who 
are current smokers) + (risk for ex-smokers x proportion of population who are ex-smokers) 
+ (risk for non-smokers x proportion of population who are non-smokers)    
 
Risk factors were assumed to act multiplicatively. The risk of developing endometrial cancer 
relative to a person with average values of all the risk factors, for example, was calculated by: 
 
 Relative risk  = (risk per kgm
-2
  ^ (observed BMI – average BMI)) * (risk per MET ^ 
(observed METs – average METs) 
 
Estimates of average 10 year absolute risk for separate cancers 
We then calculated estimates of average 10 year risk for each cancer in men and women in 
England in the same 10 year age groups from 40 to 79 years using the “Current Probability” 
method(44).This uses a life-table approach for calculating the risk of developing cancer and 
takes into account the probability of death from other causes. To obtain the data required for 
the current probability calculations we used the age- and sex-specific cancer incidence and 
mortality rates,  age- and sex-specific all-cause mortality, and mid-year population size in 
England during 2015 reported by the Office for National Statistics (available from: 
https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsandd
iseases/datasets/cancerregistrationstatisticscancerregistrationstatisticsengland and 
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https://www.ons.gov.uk/peoplepopulationandcommunity/populationandmigration/population
estimates/datasets/populationestimatesanalysistool. 
 
Estimates of 10 year absolute risk with observed values for separate cancers 
To estimate absolute cancer risk over the following 10 years for each separate cancer for an 
individual with observed values of the risk factors we multiplied the estimates derived above 
of the relative risk comparing observed with average values of the risk factors by the 
estimated average 10 year absolute risk for an individual in the same age group and of the 
same sex as the observed individual, so that: 
 
10 year absolute risk for an individual = relative risk comparing individual values to 
average values of lifestyle factors x average 10 year absolute risk for sex and age group.  
 
Estimates for the combined cancers 
To estimate the relative risk comparing observed with average values of the risk factors for 
the five cancers combined we calculated a weighted average of the five cancer-specific 
relative risks, using the average 10-year estimated absolute risk of developing each cancer in 
ten year age groups (40 years to 79 years) as weights. The 10 year estimated absolute risk for 
the combined cancers was calculated by summing the 10 year estimated absolute risks of the 
five separate cancers, assuming independence of each cancer.   
 
Estimates of relative risk comparing observed with “recommended” values of all the risk 
factors 
To allow us to present estimates of the change in risk if individuals followed a 
“recommended” lifestyle, we used the same method to calculate the relative risk comparing 
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observed with recommended values of the risk factors.  For smoking, BMI, fruit and 
vegetable consumption and physical activity we used the UK Department of Health 
guidelines to define these (being a non-smoker, having a body mass index (BMI) of 25kg/m
2
, 
eating five portions of fruit and vegetables a day, and doing 150 minutes of moderate 
physical activity per week). For alcohol and red and processed meat consumption which are 
associated with increased risk, we used zero as our recommended level in line with 
recommendations from the World Cancer Research Fund (https://www.wcrf-uk.org/). This 
decision was made to avoid appearing to encourage consumption of red or processed meat or 
alcohol among those consuming small amounts.  
  
Validation of risk model 
We externally validated the model in the EPIC-Norfolk cohort(45). This includes 25,639 men 
and women who were recruited between March 1993 and December 1997 from 27 practices 
across Norfolk and were aged between 45-74 years old at the time of recruitment.  
Participants were extensively phenotyped at baseline. Incident cases of cancer are recorded 
through linkage to the cancer registries. Smoking status and alcohol consumption were 
assessed using single questions Alcohol consumption in grams was estimated as the total 
units of drinks consumed in a week multiplied by eight. Fruit, vegetable, red meat and 
processed meat consumption were estimated from responses to a previously validated food 
frequency questionnaire and seven day food diary respectively(46): Each portion of fruit or 
vegetables was considered 80g and each portion of red or processed meat 90g, based on the 
British Dietetic Association portion sizes food factsheet (available from: 
https://www.bda.uk.com/foodfacts/portionsizesfoodfactsheet.pdf). Physical activity was 
computed from the average number of hours per week that participants reported cycling or 
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doing “other physical activity such as keep fit, aerobics, swimming or jogging”. As above, 10 
minutes of activity was considered 1 metabolic equivalent (MET)(43). 
 
We assessed the performance of the risk model in 23,768 participants (12,828 women and 
10,940 men) in the EPIC-Norfolk cohort who had at least 10 year follow-up, data for all risk 
factors and no previous history or diagnosis of any of the chosen cancers at baseline. 
Participants with prevalent and incident diagnoses of each cancer were identified through 
linkage to the National Cancer Registry. A full list of the ICD9 and ICD10 codes used for 
each cancer are in Supplementary Table 1. We truncated continuous variables at the 95
th
 
centile. We treated the outcome as a binary variable (developed one or more of the five 
cancers or did not develop any of the five cancers). For the primary analysis we assessed 
discrimination by plotting receiver operating characteristic (ROC) curves and calculating the 
area under the ROC curve (AUC). We assessed calibration graphically by plotting the 
observed risk (i.e. percentage of individuals who developed cancer) within each decile of 
predicted risk and calculated overall observed to expected ratios.  
 
All analyses were conducted using STATA/SE version 14.2(47) 
 
RESULTS  
 
Development of risk model 
Details of the lifestyle risk factors included, units for comparison, relative risks and their 
source are given in Table 1. Smoking is associated with the highest relative risk for five of 
the seven cancers considered across the two sexes, followed by BMI. The sites associated 
with the greatest number of lifestyle risk factors are colorectal and oesophageal cancer.  The 
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estimated mean 10-year risk for each of the cancers is provided in Supplementary Tables 2a 
and b. In men, colorectal cancer has the highest 10-year estimated risk of the five cancers 
between 20 and 59 years and lung cancer the highest above age 60 years. In women, breast 
cancer has the highest 10-year estimated risk at all ages, with colorectal cancer the second 
highest up to age 60 years and lung cancer above age 60 years. The mean values used in the 
calculations are reported in Supplementary Table 3. Across all age groups there were more 
former smokers amongst men than women and men consumed more alcohol, more red and 
processed meat and less fruit and, except for those aged 70-79 years, less vegetables than 
women. In both sexes, alcohol consumption, vegetable consumption and physical activity 
reduced with age while fruit consumption increased up to age 60-69.  
 
Performance of risk model 
From the 25,059 participants within the EPIC-Norfolk cohort who were aged 40-79 years at 
baseline with no existing diagnosis of any of the cancers of interest and who had 10 year 
follow-up, data for all risk factors were available for  23,768  (94.8%). Among these 
participants, 432 (3.95%) men and 647 (5.0%) women developed at least one of the cancers 
during the 10 year follow-up (Tables 2 and 3). Compared to those who did not develop at 
least one of the cancers, those who did were on average older and more likely to be female, 
have a higher BMI, report less physical activity and be a current smoker. Differences in red 
meat, processed meat, fruit and vegetable consumption were small.  
 
The mean relative risk compared with the ‘recommended’ lifestyle was 1.76 (SD 0.94, range 
0.72 to 8.0). In men there was good discrimination with an AUC for the combined model of 
0.71 (95% CI 0.69-0.73) (Figure 1a). There was also reasonable agreement between the 
predicted absolute 10-year risk and the observed risk (Figure 2a) although overall the risk 
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model underestimated risk with an observed:expected ratio of 1.34 (95% CI 1.04-1.73). 
Discrimination was less good in women with an AUC of 0.59 (95% CI 0.57 – 0.61) (Figure 
1b).Overall calibration was better in women (Figure 2b) with the overall observed to 
expected ratio 1.08 (95% CI 0.90-1.30) but at higher risks the model overestimated risk.  
  
Figures 3a and b show the AUC for the five individual cancers as well as the combined 
model for men and women respectively. In both sexes the models for lung cancer had the 
highest AUCs (0.80 (95%CI 0.77-0.83) for men and 0.82 (95% CI 0.76-0.87) for women). 
The lowest AUCs were for breast and endometrial cancer in women and kidney cancer in 
men.  
 
DISCUSSION 
 
Key findings 
We have developed and validated models in men and women for prediction of the individual 
or combined absolute risk of developing one or more of the five cancers for which the most 
cases are potentially preventable through lifestyle change. The models can also be used to 
present relative risks compared with either an average or a recommended lifestyle. The 
models include information about established lifestyle risk factors in a format that is readily 
obtainable from individuals or their medical records without the need for laboratory tests. The 
combined models had good discrimination in men (AUC 0.71) and reasonable discrimination 
in women (AUC 0.59). The discrimination for the individual cancers ranged from very good 
for lung cancer (AUC over 0.8 in both men and women), to poor for breast cancer (AUC 
0.56). Overall calibration, as assessed graphically, was reasonable. The models could be used 
to identify those most likely to benefit from lifestyle interventions and to demonstrate the 
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impact of change to individuals and comparison of their risk to others to contribute to 
decisions to change behaviour. 
 
Strengths and Limitations 
To our knowledge these are the first risk models incorporating only modifiable factors 
alongside age and sex that have been developed for multiple cancers in a UK population. 
Particular strengths include the use of the European Code against Cancer 4
th
 Edition to 
identify the risk factors associated with each of the individual cancers; the use of data from 
systematic reviews to obtain estimates of the relative risk for each lifestyle factor and each of 
the relevant cancers; the use of nationally representative datasets to obtain average values for 
each risk factor; and assessment of the performance of the models in a large population-based 
UK cohort. There are, however, a number of limitations. Firstly, except for the association 
between alcohol and colorectal cancer, we assumed a log-linear relationship between 
exposure and relative risk. This is supported by the absence of significant non-linearity 
reported in many of the meta-analyses but may have influenced estimates of relative risk for 
extreme values of each risk factor.  
 
Estimating the absolute 10-year risk for an individual required us to estimate the average 10-
year risk at varying ages for each of the cancers. We did this using the current probability 
method. This involves calculating the number of cases that would occur within each age band 
on the basis of the person-years at risk and age-specific incidence rate(44). This has the 
advantage over cumulative risk estimates in that it takes into account competing risks. 
However, when it is calculated using routine incidence data, which includes multiple primary 
cancers, such as the data from ONS which we used, the method is actually estimating the 
average number of primary cancers per person rather than the probability of a person getting 
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cancer. As a result the method tends to overestimate lifetime risk of getting cancer for 
individual cancers. However, the difference between the estimates obtained from this method 
and the ‘gold standard’ estimates have been shown to be small(48). 
 
Advantages of using the EPIC-Norfolk cohort for validation of the models include the 
comprehensive phenotyping, completeness of data, and linkage to national cancer registries. 
However, although the cohort at baseline was representative of the Health Survey for 
England population for age, sex and BMI, it had fewer current smokers(45) and participants 
were recruited from only one geographical region in the East of England. The models 
therefore need to be assessed in other populations before inferences can be made about model 
generalizability(49).  
 
Comparison with existing literature 
As we aimed to develop models that could be used within routine practice, we have not 
included all factors that are predictive of each cancer. We also specifically sought to include 
variables in a way that they could be collected easily and quickly. Had we included greater 
detail for variables, for example using pack years of smoking rather than a categorical 
smoking status variable, model performance may have been improved. Despite this, the 
discrimination for the individual cancers are comparable or better than many other published 
risk models. For example: the AUCs of 0.66 and 0.68 for colorectal cancer in men and 
women respectively are comparable with published models that also include family history 
and more complex variables(50); the AUC of over 0.80 for lung cancer in both men and 
women is better than the range of 0.61 to 0.81 reported in external validation of nine models, 
all of which included age and smoking behaviour(51); and the AUC of 0.74 for bladder 
cancer in men is better than the only other published model(52) which includes smoking and 
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exposure to diesel, aromatic amines, dry cleaning fluids, radioactive materials and arsenic 
and had an AUC of 0.70 (95% CI 0.67-0.73) in split-sample validation.  
 
With an AUC of 0.55, the model for breast cancer has the lowest discrimination. This is 
consistent with the literature in which models incorporating a combination of age, age at 
menarche, first live birth and menopause, breast biopsy and family history of breast cancer  
still only have AUCs between 0.59 and 0.67 in population based cohorts(53,54). 
Furthermore, a recent extension of the Rosner-Colditz prediction model incorporating 22 risk 
factors had an AUC of only 0.65 in split-sample validation(55). As described previously, the 
relatively weak predictive ability of these models may arise because risk factors with large 
associations such as mutations in the BRCA1 or BRCA2 genes have low prevalence, and risk 
factors such as early age at menarche or late age at first birth are common amongst women 
who never go on to develop breast cancer and have only modest associations with risk.  
 
The AUCs for endometrial cancer (AUC 0.61) and oesophageal cancer (AUC 0.65) were also 
lower than other published models with AUCs of 0.68 (95% CI 0.66-0.70) in external 
validation(56) and 0.77 (0.68-0.85) in cross-validation(57) for endometrial cancer and 0.79 
(95% CI 0.75-0.83) in cross-validation(52) and 0.75 (95% CI 0.66-0.84) in 10-fold cross-
validation(58) for oesophageal cancer. This may reflect the absence from our models of 
hormonal factors for endometrial cancer and reflux symptoms or non-steroidal anti-
inflammatory drugs for oesophageal cancer. To our knowledge no other risk models have 
been developed for kidney cancer alone.  
 
The discrimination of the combined model for the five most common preventable cancers in 
men (AUC 0.71) is also comparable with the Healthy Heart Score, a lifestyle-based 
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prediction model for cardiovascular disease(59). The Healthy Heart Score includes age, 
smoking status, BMI, physical activity, alcohol and a composite diet score incorporating 
fibre, fruit and vegetables, nuts, sugar-sweetened beverages and red and processed meats. In 
split-sample validation within large US based cohorts it had a Harrell’s C-index of 0.77 (95% 
CI 0.76-0.79) in men and 0.72 (95% CI 0.71-0.74) in women. The performance of the 
combined model for the five most common preventable cancers in women (AUC 0.59) was, 
however, substantially poorer. This is in part due to the poor performance of the risk score for 
breast cancer which is the most common cancer in women and so has the greatest weighting 
within the combined model. As mentioned above, hormonal factors are also known to 
influence risk of cancer in women and are not included in our models.   
 
Implications for clinicians, researchers and policy makers 
The risk models developed here are applicable to individuals aged 40 to 79 years and enable 
presentation of information about the impact of lifestyle on future risk of cancer. By focusing 
on the most common preventable cancers and modifiable risk factors which can be easily 
obtained without the need for laboratory or imaging tests, they could be used as the first step 
in a multi-stage risk stratification programme to identify those most likely to benefit from 
lifestyle interventions and to motivate individuals to change their behaviour. For example, a 
65 year old man who weighs 80kg, is 1.7m tall, is a current smoker, drinks four units of 
alcohol per day, eats three portions of red meat and two portions of processed meat per week 
and one portion or fruit and vegetables per day, and does two hours of moderate physical 
activity per week has an estimated 10-year risk of 8%. If he lost 5kg of weight, quit smoking, 
reduced alcohol to one unit per day and red and processed meat to two portions per week, 
increased fruit and vegetables to five portions per day and did three hours of physical activity 
per week, his risk would reduce to 4%. Previous research has shown that public awareness of 
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the impact of such lifestyle changes on cancer risk is low: only 3% of people are aware that 
being overweight can increase their risk of cancer; less than a third are aware that physical 
activity could help reduce risk(60–63); and one in seven people believe that lifetime risk of 
cancer is unmodifiable(64). Although communicating personalised risk information on its 
own is unlikely to lead to much sustained behaviour change(65) using these risk models to 
illustrate the impact of lifestyle change and allow individuals to compare their risk to average 
people of their age and sex and the risk if they followed a recommended lifestyle may help 
motivate change at an individual level when combined with other established behaviour 
change techniques(66). This would then complement wider collective approaches to shifting 
population distributions of behaviour and risk factors.    
 
This risk assessment could be conducted within existing healthcare and prevention 
services(8) or made available online. Further research is now needed to assess the 
performances of the models in other populations, develop a user-friendly interface in which 
these models can be incorporated into clinical practice, and implementation studies 
quantifying the potential benefits and harms of providing such information.  
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Table 1. Estimates of the association between risk factors and individual cancers 
 
Risk factor Unit / comparison Relative risk  
Physical 
activity(22) 
1 MET-hour per week Breast(25)  – 0.9970 
Colorectal(26)  –0.9940 
Endometrial(27)  – 0.9933 
Smoking(18) Current and former 
smokers compared 
with non-smokers 
Current smokers 
  Lung(28) – 8.96 
  Colorectal(28) - 1.2 
  Oesophageal(28) – 2.5 
  Kidney(28) – 1.52 
  Bladder(29) – 3.14 
Former smokers 
  Lung(28) – 3.85 
  Colorectal(28) - 1.2 
  Oesophageal(28) – 2.03 
  Kidney(28) – 1.25 
  Bladder(29) – 1.83 
Red meat(20) 1 gram per day Colorectal(30) – 1.0016 
Processed 
meat(20) 
1 gram per day Colorectal(30) – 1.0033   
Alcohol(19) 1 gram per day Breast(31) – 1.0068 
Colorectal(32) – ln(RR) = 0.006992 x g/day – 0.00001 x g/day2 
Oesophageal(33) – 1.0129 
BMI(25) 1 kg/m2  Breast (postmenopausal*) (30) – 1.0229 
Breast (premenopausal*) (30)  - 0.9856  
Colorectal(33) – 1.030 
Oesophageal(34) – 1.087 
Kidney(33) – 1.04 
Endometrial(30) – 1.034 
Fruit(20) 1 gram per day Oesophageal(35) – 0.994 
Lung(36) – 0.99 
Vegetables(20) 1 gram per day Oesophageal(35) – 0.9972 
* Defined as below 50 years or 50 years and over such that premenopausal = age < 50 years 
and post-menopausal = age ≥ 50 years 
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Table 2. Demographic and lifestyle characteristics of the EPIC-Norfolk cohort 
 Validation cohort 
 
 
No incident cancer 
n = 22 689 
Incident cancer 
n = 1 079 
Age (years)     
      Mean (SD) 58.9 (9.3) 62.9 (8.6) 
      40-49 (%) 22.2 8.7 
      50-59 (%) 32.2 27.2 
      59-60 (%) 30.7 37.4 
      69-70 (%) 15.0 26.8 
Sex     
      Female (%) 53.7 60.0 
      Male (%) 46.3 40.0 
BMI (kg/m2)   
      Mean (SD) 26.3 (3.9) 26.9 (4.3) 
Smoking status   
      Never (%) 42.39 43.0 
      Former (%) 46.13 42.5 
      Current (%) 11.5 14.5 
Alcohol intake (units per day)   
      Mean (SD) 7.5 (8.2) 7.2 (8.2) 
Physical activity (MET-h/d)   
      Mean (SD) 9.3 (13.2) 8.4 (13.0) 
Red meat consumption (g/week)   
      Mean (SD) 39.3 (25.3) 39.8 (25.0) 
Processed meat consumption 
(g/week) 
  
      Mean (SD) 17.9 (12.9) 18.0 (12.9) 
Fruit consumption (g/day)   
      Mean (SD) 251.2 (149.6) 254.7 (154.2) 
Vegetable consumption (g/day)   
      Mean (SD) 251.2 (107.11) 252.3 (105.6) 
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Table 3. Incident cases of cancer (n, %) within the EPIC-Norfolk validation cohort 
Cancer Men (n=10,940) Women (n=12,828) 
Lung 142 (1.30) 54 (0.42) 
Colorectal 184 (1.68) 138 (1.08) 
Kidney 28 (0.26) 16 (0.12) 
Breast ---- 367 (2.86) 
Bladder 47 (0.43) ---- 
Endometrial ---- 84 (0.65) 
Oesophageal 35 (0.32) ---- 
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FIGURE LEGENDS 
Figure 1. Receiver operating characteristic curves for the combined model in a) men; and b) 
women. 
Figure 2. Calibration plots of observed risk in the EPIC-Norfolk cohort within each decile of 
predicted risk in a) men; and b) women. Error bars represent the 95% confidence intervals.  
Figure 3. Area under the receiver operating characteristic curves (AUC) for the five models of 
individual cancers and the combined model for a) men; and b) women. 



